Literature DB >> 239223

The absence of renal bicarbonate reabsorption maxima during carbonic anhydrase inhibition.

L C Garg.   

Abstract

Present studies were performed to examine the effect of carbonic anhydrase inhibition on bicarbonate reabsorption under experimental conditions where extracellular fluid volume expansion was minimized. The data showed no tubular maximum for bicarbonate reabsorption in the normal state or after carbonic anhydrase inhibition. The data support a model which assumes that the bicarbonate reabsorption is accomplished by two processes. One process is independent of protonation from H+ secretion into the tubule and probably involves reabsorption of bicarbonate ion as such. This process has an unlimited capacity for reabsorption of bicarbonate. The contribution of this process increases with an increase in plasma bicarbonate. The second process is dependent on protonation, through the intracellular hydration of carbon dioxide. The relative contribution, through the intracellular hydration of carbon dioxide. The relative contribution of this process is normally about 33% and decreases with increased plasma bicarbonate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239223

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Failure of parathyroid hormone and cyclic AMP to inhibit renal carbonic anhydrase.

Authors:  L C Garg
Journal:  Pflugers Arch       Date:  1976-11-30       Impact factor: 3.657

2.  Renal bicarbonate reabsorption in the new-born dog.

Authors:  L I Kleinman
Journal:  J Physiol       Date:  1978-08       Impact factor: 5.182

3.  Effect of luminal and peritubular HCO3(-) concentrations and PCO2 on HCO3(-) reabsorption in rabbit proximal convoluted tubules perfused in vitro.

Authors:  S Sasaki; C A Berry; F C Rector
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

4.  Renal adaptation to potassium in the adrenalectomized rabbit. Role of distal tubular sodium-potassium adenosine triphosphatase.

Authors:  L C Garg; N Narang
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.